Allay Therapeutics is pioneering products to help patients recover from post-surgical pain management. Current pain management products provide several days of pain relief, much shorter than the weeks or months of post-surgical recuperation that millions of patients cope with. To resolve this, Allay has developed the first technology designed to deliver weeks of localized pain management. Allay’s proprietary technology combines validated non-opioid analgesics and biopolymers to create candidates that deliver targeted pain relief. By tuning the drug-biopolymer architecture that alters the analgesic release profile, Allay can design their technology for a variety of potential applications. Allay’s lead candidate, ATX-101, is designed to support recuperation from total knee-replacement surgery.

<p>Allay Therapeutics is pioneering products to help patients recover from post-surgical pain management. Current pain management products provide several days of pain relief, much shorter than the weeks or months of post-surgical recuperation that millions of patients cope with. To resolve this, Allay has developed the first technology designed to deliver weeks of localized pain management. Allay’s proprietary technology combines validated non-opioid analgesics and biopolymers to create candidates that deliver targeted pain relief. By tuning the drug-biopolymer architecture that alters the analgesic release profile, Allay can design their technology for a variety of potential applications. Allay’s lead candidate, ATX-101, is designed to support recuperation from total knee-replacement surgery.</p>


Allay Therapeutics

Founded: 2017
Location: Menlo Park, CA
Employee range: 11 - 50
Clinical stage: Clin2
Therapy area: Knee replacement surgery pain
Drug types: PN, ANE
Lead product: ATX-101
Funding: $60M C Sep 2021

Drug notes:

About:

Jobs: